-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integrated Biopharma Inc quarterly Deferred Federal Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q1 2024.
- Integrated Biopharma Inc Deferred Federal Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $81K, a 800% increase year-over-year.
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Quarterly Growth (%)